Knowledge@SMU

Authors

Knowledge@SMU

Publication Type

Journal Article

Publication Date

5-2011

Abstract

Entrepreneurs in the biotech industry require large risk thresholds. For one, the business of research is an expensive one, the results of which may not necessarily translate to commercial viability. Investors with the foresight and patience for such long-term, high-risk ventures are also hard to come by. At a talk organised by SMU's Lee Kong Chian School of Business, Dr. Steven Fang, founder of CordLife, shared insights on what 'biotechopreneurship' entails.

Disciplines

Business | Entrepreneurial and Small Business Operations | Technology and Innovation

Copyright Owner and Holder

Copyright © Singapore Management University 2012

Article ID

1351

Subject(s)

Innovation and Entrepreneurship

Share

COinS